The US-based pharmaceutical company Eli Lilly's price reduction on its already cheapest insulin products signifies the tough competition on the US insulin market, in which the company is fighting for its market share with, for instance, Denmark's Novo Nordisk.
So says Senior Chief Analyst at Sydbank Søren Løntoft Hansen to Marketwire.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Lundbeck chairman demands change: "We can't live with this"
Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.
Coloplast could win big on Polish reimbursement changes
The Polish Ministry of Health has increased the reimbursement amount for hydrophilic catheters, which Coloplast supplies. The Danish medtech company calls the new scheme a "breakthrough."
Several positive elements in Eli Lilly Q3 report, says analyst
.jpg)
An analyst at Sydbank thinks that Eli Lilly's third quarter report includes a number of positive elements, and emphasizes that this could also be good news for competitor Novo Nordisk.
Eli Lilly upgrades earnings per share guidance
On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.
Cloud computing saves money and cuts carbon emissions at Novo Nordisk
Integrating cloud solutions has helped with Novo Nordisk's sustainable transition, Danish media reports.
Training manager 
GxP QA Compliance Manager for Quality Assurance 
Senior Legal Advisor 
Regulatory Science Specialist 
Head of Engineering, Syntese 
QA Specialist wanted 
Senior Manager Pharmaceutical Development and Manufacturing 
Senior Clinical Trial Manager 
Senior Director, Global Regulatory Lead 
Global Product Manager 
Associate Director – MedTech Manufacturing 
Key Account Manager – Lab & Diagnostic 
Medical Director 
Application Manager (GxP Systems) - Zealand Pharma 
Clinical Documentation Specialist 
Jr. Software Developer, Cardiac Applications – Medical Devices, DK